No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina / NY / Florida       

American Injectables Announces Validation of its Tampa Operations

What To Know

  • The focus and dedication of the entire organization is to become an important US-based supplier of essential medicines to the acute care market, and to become a partner of choice for industry through their sterile manufacturing of vials and ready-to-use prefilled syringe products.
  • American Injectables announced that the company has successfully completed the commissioning and qualification of its newly constructed facility in addition to the completion of Series A financing.

American Injectables announced that the company has successfully completed the commissioning and qualification of its newly constructed facility in addition to the completion of Series A financing.

Key accomplishments were qualifying the facility and utilities as well as completing the first successful series of media fills for the sterile core and vial filling line. During a recent interview, CEO Adam Levitt made these comments,

“We are excited to start registration batches for FDA submission in the coming months and preparing for our first FDA inspection and approval.”

Mr. Levitt went on to say, “I am further announcing the addition of Dr Vijay Nekkanti, VP R&D to the leadership team. Dr Nekkanti most recently was leading R&D for Humanwell and has held leadership roles with Custopharm, and Dr. Reddy’s Lab and Pfizer. I am very excited about this new critical hire. American Injectables, Inc is now well-positioned with Integrated Product Development and Manufacturing engine that quickly and flexibly brings new products to market. With the addition of Dr. Nekkanti we have completed building a world class leadership team.”

Chairman Subhanu Saxena said, “I am delighted to see American Injectables progress with this round of funding. This successful funding round reflects the success we’ve achieved through facility qualification and completion of media fills. The focus and dedication of the entire organization is to become an important US-based supplier of essential medicines to the acute care market, and to become a partner of choice for industry through their sterile manufacturing of vials and ready-to-use prefilled syringe products.”

[Bourne Partners advised American Injectables in the fundraising.]

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More

Advertise wiith Medical Device News Magazine

By using this website you agree to accept Medical Device News Magazine Privacy Policy